In a head-to-head sense, PDE5 inhibitors still remain the first step for pure ED, whereas PT-141 is carving out a role for cases beyond PDE5is reach or adding to their effect
It is not intended for human or animal consumption, clinical use, diagnostic use, therapeutic use, cosmetic use, or as a food or supplement
Women over 40 face unique challenges as declining estrogen and progesterone levels affect serotonin receptor density, GABA sensitivity, and neuroinflammatory markers
The regulatory distinction you made is so crucial: the July FDA advisory committee meeting on BPC-157, TB-500, KPV, and others is about compounding access through the 503A pathway, not approval, and not evidence of efficacy